GT
INVA icon

Glenmede Trust’s Innoviva INVA Stock Holding History

Glenmede Trust’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
14,572
+12
+0.1% +$275 ﹤0.01% 1136
2026
Q1 		$339K Sell
14,560
-2,351
-14% -$50.6K ﹤0.01% 1106
2025
Q4 		$338K Buy
+16,911
New +$330K ﹤0.01% 1091
2025
Q1 		$355K Buy
+19,562
New +$351K ﹤0.01% 1020
2020
Q4 		– Sell
-1,328
Closed -$13K – 1715
2020
Q3 		$13K Buy
1,328
+108
+9% +$1.37K ﹤0.01% 1776
2020
Q2 		$17K Buy
1,220
+381
+45% +$5.18K ﹤0.01% 1650
2020
Q1 		$11K Hold
839
– – ﹤0.01% 2389
2019
Q4 		$11K Buy
839
+436
+108% +$5.35K ﹤0.01% 2389
2019
Q3 		$4K Buy
403
+127
+46% +$1.52K ﹤0.01% 2705
2019
Q2 		$4K Hold
276
– – ﹤0.01% 2689
2019
Q1 		$3K Sell
276
-1,370
-83% -$22.2K ﹤0.01% 2746
2018
Q4 		$27K Buy
+1,646
New +$26.7K ﹤0.01% 1853

Other funds holding INVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Glenmede Trust's INVA Position: Q2 2026 in Review

Glenmede Trust increased its Innoviva (INVA) stake by 0.08% in Q2 2026, buying an estimated $275 and bringing the position to 14,572 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Glenmede Trust first reported a position in INVA in Q4 2018 and has held it in 12 quarters since. The position peaked at $355K in Q1 2025. 309 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Glenmede Trust held 14,572 shares of Innoviva worth $331K as of Q2 2026.
  • Glenmede Trust bought 12 Innoviva shares in Q2 2026, an estimated $275.
  • Innoviva made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1136 holding.
  • Glenmede Trust first reported a position in Innoviva in Q4 2018 and has held it in 12 quarters since.
  • Glenmede Trust's Innoviva position peaked at $355K in Q1 2025.
  • 309 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.